164 related articles for article (PubMed ID: 34707568)
1. Case Report: Medullary Thyroid Cancer Workup Initiated by Unexpectedly High Procalcitonin Level-Endocrine Training Saves Life in the COVID-19 Unit.
Sira L; Balogh Z; Vitális E; Kovács D; Győry F; Molnár C; Bodor M; Nagy EV
Front Endocrinol (Lausanne); 2021; 12():727320. PubMed ID: 34707568
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.
Trimboli P; Seregni E; Treglia G; Alevizaki M; Giovanella L
Endocr Relat Cancer; 2015 Jun; 22(3):R157-64. PubMed ID: 25934688
[TBL] [Abstract][Full Text] [Related]
4. Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows.
Censi S; Di Stefano M; Repaci A; Benvenuti T; Manso J; Pagotto U; Iacobone M; Barollo S; Bertazza L; Galuppini F; Benna C; Pennelli G; Plebani M; Faggian D; Colombo C; Fugazzola L; Mian C
Front Endocrinol (Lausanne); 2021; 12():754565. PubMed ID: 34721303
[TBL] [Abstract][Full Text] [Related]
5. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
[TBL] [Abstract][Full Text] [Related]
6. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.
Martins A; Gonçalves A; Almeida T; Midões A
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542
[TBL] [Abstract][Full Text] [Related]
7. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
Lim SK; Guéchot J; Vaubourdolle M
Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
Murphy DC; Johnson SJ; Aspinall S
Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.
Giovanella L; Imperiali M; Piccardo A; Taborelli M; Verburg FA; Daurizio F; Trimboli P
Eur J Clin Invest; 2018 Jun; 48(6):e12934. PubMed ID: 29635700
[TBL] [Abstract][Full Text] [Related]
10. Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2014 Aug; 99(8):2986-94. PubMed ID: 24840813
[TBL] [Abstract][Full Text] [Related]
11. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer.
Fugazzola L
Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250
[No Abstract] [Full Text] [Related]
12. Prediction of lateral neck lymph node metastasis according to preoperative calcitonin level and tumor size for medullary thyroid carcinoma.
Bae SY; Jung SP; Choe JH; Kim JS; Kim JH
Kaohsiung J Med Sci; 2019 Dec; 35(12):772-777. PubMed ID: 31483088
[TBL] [Abstract][Full Text] [Related]
13. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
Trimboli P; Giovanella L
Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M
Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
16. Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature.
Appetecchia M; Barnabei A; Pompeo V; Sentinelli S; Baldelli R; Corsello SM; Torino F
BMC Endocr Disord; 2014 Oct; 14():84. PubMed ID: 25306429
[TBL] [Abstract][Full Text] [Related]
17. What Is the Extent of Neck Dissection in Medullary Thyroid Carcinoma?
Asarkar A; Chang BA; Nathan CO
Laryngoscope; 2021 Mar; 131(3):458-459. PubMed ID: 32311764
[No Abstract] [Full Text] [Related]
18. Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.
Walter MA; Meier C; Radimerski T; Iten F; Kränzlin M; Müller-Brand J; de Groot JW; Kema IP; Links TP; Müller B
Cancer; 2010 Jan; 116(1):31-40. PubMed ID: 19890958
[TBL] [Abstract][Full Text] [Related]
19. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
20. Incidental diagnosis of medullary thyroid carcinoma due to persistently elevated procalcitonin in a patient with COVID-19 pneumonia: A case report.
Saha A; Mukhopadhyay M; Paul S; Bera A; Bandyopadhyay T
World J Clin Cases; 2022 Jul; 10(20):7171-7177. PubMed ID: 36051107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
